Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Current Pharmaceutical Design|December 7, 2010
Therapeutic antibodies in HIV treatment--classical approaches to novel advancesIrene A Abela, Lucy Reynell, Alexandra TrkolaPlos Pathogens|April 13, 2012
Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodiesIrene A Abela, Livia Berlinger, Merle Schanz, et al.Current Opinion in Microbiology|September 11, 2004
HIV-host interactions: vital to the virus and key to its inhibitionAlexandra TrkolaCurrent Opinion in Microbiology|October 27, 2004
HIV-host interactions: vital to the virus and key to its inhibitionAlexandra TrkolaSTAR Protocols|September 1, 2024
ART-DEX: A novel strategy to monitor broadly neutralizing antibody activity during antiretroviral therapy of HIV-1Magdalena Schwarzmüller, Alexandra TrkolaThe Journal of Experimental Medicine|March 2, 2011
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1Claudia R Ruprecht, Anders Krarup, Lucy Reynell, et al.The Lancet. Infectious Diseases|October 26, 2023
Vaccinating people living with HIV: a fast track to preventive and therapeutic HIV vaccinesAlexandra Trkola, Penny L MooreVirus Research|October 24, 2015
HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolutionCarsten Magnus, Lucia Reh, Alexandra TrkolaRetrovirology|July 30, 2018
Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?Harini Subbaraman, Merle Schanz, Alexandra TrkolaPageof 14